DiCE Advocates for Awareness at PANCAID Stakeholder Event On 15 January 2025, DiCE actively participated in the PANCAID Stakeholder Event at the European Parliament in Brussels, organised by Pancreatic […]

IMPROVE-2 Trial: A New Treatment Approach for mCRC The IMPROVE-2 trial is exploring a new way to treat metastatic colorectal cancer (mCRC) by comparing intermittent versus continuous use of […]

Educational Programme on Metastatic Pancreatic Cancer Now Available Metastatic pancreatic ductal adenocarcinoma (mPDAC) is an aggressive and often late-diagnosed cancer with poor prognoses. Early detection remains […]

Advancing Rare Cancer Care: DiCE at the EURACAN Board Meeting On the 7th and the 8th of November, Laura Urena from Digestive Cancers Europe (DiCE) and a member of EURACAN Patient Advocacy Group (EPAG), […]

Help Shape the Future of Gastric Cancer Screening in Europe The TOGAS consortium invites you to participate in a survey on gastric cancer screening. TOGAS is an EU co-funded project exploring the […]

DiCE at ESMO 2024 Earlier this month, part of the DiCE Medical and Scientific Team attended the ESMO (European Society for Medical Oncology) Congress 2024 in […]

DiCE Attends the TOGAS EU Project Consortium Meeting and Conference Zorana Maravic, our CEO, and Ana Martins, DiCE medical and scientific project manager, participated in the TOGAS Consortium Meeting and TOGAS […]

DiCE Attends The Horizon Europe Cancer Mission ‘Diagnosis and Treatment’ Cluster Meeting On September 12th in sunny Barcelona, DiCE, a member of the SAGITTARIUS EU Project, participated in the Horizon Europe Cancer Mission’s ‘ […]

DiCE Elevates Patient Advocacy Skills at WECAN Academy in Barcelona Digestive Cancers Europe (DiCE) had the incredible opportunity to attend the WECAN Academy in the sunny city of Barcelona. Our goal at DiCE is to […]

PerMICCion: A Study on Transforming Colorectal Cancer Prevention and Treatment through Gut Microbiome Research More than 5 million people worldwide are living with colorectal cancer (CRC), making it the third most common cancer globally. Alarmingly, this […]

Lynch Syndrome and the Challenge of Getting a Diagnosis Lynch Syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is a hereditary condition characterised by a high risk of various […]

Beating Cancer Inequalities in the EU – An OECD Report Summary Cancer is a significant health problem in Europe. It is estimated that every 5 minutes, a person is diagnosed with a type of cancer. It is expected […]

Lynch Syndrome, the Most Common of the Rarest 22 March is Lynch Syndrome Day, also known as Hereditary Non-Polyposis Colorectal Cancer, so we will remind people that those who have Lynch […]